Pradžia › Prostatos vėžys › Oregon
Prostatos vėžys klinikiniai tyrimai Oregon
38 tyrimai dėl Prostatos vėžys ieško dalyvių vietose Oregon.
Miestai Oregon
Oficialus tyrimo tekstas (anglų kalba)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-10-02 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- ir dar 7
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- ir dar 1
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-29 · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-28 · NCT06095089Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 120 · Vyrams · Atnaujinta 2026-09-28 · NCT04706663A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-24 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 100 · Vyrams · Atnaujinta 2026-09-22 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-22 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-18 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT06925737Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-11 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-10 · NCT05946213MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
- Oregon Health & Science University, Portland
Renkami dalyviai
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-01 · NCT05710380A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-31 · NCT05726292Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 99 · Vyrams · Atnaujinta 2026-08-27 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-26 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-25 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- ir dar 5
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-19 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- ir dar 8
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-07-14 · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-06-25 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-06-15 · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
Renkami dalyviaiStebimasis tyrimas
Amžius 21 ir vyresni · Vyrams · Atnaujinta 2026-05-22 · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Vyrams · Atnaujinta 2026-05-15 · NCT04472338A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-05-12 · NCT06879041Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Renkami dalyviai
Amžius 65 ir vyresni · Vyrams · Atnaujinta 2026-05-06 · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- ir dar 9
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-01-29 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-01-22 · NCT06470243cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-01-20 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
Renkami dalyviai2 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-05-29 · NCT06049355Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2022-04-20 · NCT03753243Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.